Migraines affect around one in seven people in the UK. Yet despite being one of the most common neurological conditions in the world, they are still widely misunderstood. Many people assume a migraine is simply a very bad headache. In reality, it is a complex condition that can leave people unable to work, socialise, or carry out everyday tasks for hours or even days at a time.
So what exactly is a migraine, and why does it affect so many people so severely?
What Makes a Migraine Different
A migraine is not just head pain. It is a neurological event that typically causes intense, throbbing pain on one side of the head, often alongside nausea, vomiting, and extreme sensitivity to light and sound. Some people also experience what is known as an aura before the pain begins. This can include visual disturbances such as flashing lights or blind spots, as well as tingling in the face or hands.
Attacks can last anywhere from four hours to three days. For people who experience migraines regularly, this level of disruption can have a serious impact on their mental health, relationships, and careers.
Who Gets Migraines?
Migraines can affect anyone, but they are around three times more common in women than men. Hormonal changes, particularly those linked to the menstrual cycle, are thought to be a significant trigger for many women. Other common triggers include stress, disrupted sleep, dehydration, certain foods, and changes in the weather.
Genetics also plays a role. If a parent has migraines, their child is more likely to develop them too. Researchers believe that people who experience migraines have a nervous system that reacts more strongly to changes in the environment, though the precise mechanisms are still being studied.
How Are Migraines Treated?
There is currently no cure for migraines. Treatment focuses on managing attacks when they happen and, in some cases, reducing how often they occur. Over-the-counter pain relief such as ibuprofen or paracetamol can help with mild attacks. For more severe episodes, doctors may prescribe triptans, a class of medicines designed specifically to treat migraines by narrowing blood vessels and blocking pain signals.
Preventive treatments are also available for people who have frequent attacks. These range from beta-blockers and antidepressants to newer injectable medicines that target a protein called CGRP, which is known to play a key role in triggering migraines.
The Role of Research in Improving Treatment
Despite some progress, a significant number of people still do not respond well to existing treatments. This has made migraine research an important area of focus in the UK and internationally. Clinical trials migraines are currently underway at research sites across England, investigating new medicines and approaches that could offer better relief for those who have not responded to standard care.
Research studies are conducted under strict ethical oversight and all participants go through a detailed screening process before taking part. Participants are provided with full information about the study before they agree to join, and they are free to withdraw at any time.
Living With Migraines
Many people with migraines find that keeping a diary helps them to identify their personal triggers and manage their condition more effectively. Tracking things like sleep patterns, diet, stress levels, and menstrual cycle can reveal patterns that are not always obvious.
Regular sleep, staying well hydrated, and managing stress through exercise or mindfulness are also commonly recommended as part of a broader self-management approach. While these strategies do not work for everyone, they can reduce both the frequency and severity of attacks for some people.
Why More Needs to Be Done
Despite how common migraines are, research into the condition has historically been underfunded compared to other neurological disorders. That is changing, partly due to growing awareness and advocacy from people living with the condition. New treatments emerging from clinical trials migraines are giving renewed hope to the millions of people in the UK who have struggled to find effective relief.
Migraines are not something people simply have to put up with. Greater understanding, better treatment options, and continued investment in research are all essential to improving quality of life for those affected.
